Business
Press Release Dec 22 2022
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Zydus receives final approval and 180 days shared exclusivity from the USFDA for Selexipag Tablets".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 22, 2022, titled \"Zydus receives final approval and 180 days shared exclusivity from the USFDA for Selexipag Tablets\". View Attachment","length":366,"tagName":"div"}]